Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction

Bibliographic Details
Main Authors: Wenqi Wu, Su Liu, Linyan Tian, Cheng Li, Yanan Jiang, Jinhuan Wang, Yangyang Lv, Jing Guo, Donghui Xing, Yixin Zhai, Huimeng Sun, Yuhang Li, Luying Zhang, Xiang He, Kaiping Luo, Hongjie Zhan, Zhigang Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1180076/full
_version_ 1797808877881786368
author Wenqi Wu
Su Liu
Linyan Tian
Cheng Li
Yanan Jiang
Jinhuan Wang
Yangyang Lv
Jing Guo
Donghui Xing
Yixin Zhai
Huimeng Sun
Yuhang Li
Luying Zhang
Xiang He
Kaiping Luo
Hongjie Zhan
Zhigang Zhao
Zhigang Zhao
author_facet Wenqi Wu
Su Liu
Linyan Tian
Cheng Li
Yanan Jiang
Jinhuan Wang
Yangyang Lv
Jing Guo
Donghui Xing
Yixin Zhai
Huimeng Sun
Yuhang Li
Luying Zhang
Xiang He
Kaiping Luo
Hongjie Zhan
Zhigang Zhao
Zhigang Zhao
author_sort Wenqi Wu
collection DOAJ
first_indexed 2024-03-13T06:44:13Z
format Article
id doaj.art-5b72d4122ac34840ad4388358a49299f
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-13T06:44:13Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-5b72d4122ac34840ad4388358a49299f2023-06-08T11:19:09ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-06-011410.3389/fgene.2023.11800761180076Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis predictionWenqi Wu0Su Liu1Linyan Tian2Cheng Li3Yanan Jiang4Jinhuan Wang5Yangyang Lv6Jing Guo7Donghui Xing8Yixin Zhai9Huimeng Sun10Yuhang Li11Luying Zhang12Xiang He13Kaiping Luo14Hongjie Zhan15Zhigang Zhao16Zhigang Zhao17Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, Chinahttps://www.frontiersin.org/articles/10.3389/fgene.2023.1180076/fullDLBCLmicrotube-associated genesprognostic modeltargeting therapyTMEM63A
spellingShingle Wenqi Wu
Su Liu
Linyan Tian
Cheng Li
Yanan Jiang
Jinhuan Wang
Yangyang Lv
Jing Guo
Donghui Xing
Yixin Zhai
Huimeng Sun
Yuhang Li
Luying Zhang
Xiang He
Kaiping Luo
Hongjie Zhan
Zhigang Zhao
Zhigang Zhao
Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
Frontiers in Genetics
DLBCL
microtube-associated genes
prognostic model
targeting therapy
TMEM63A
title Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
title_full Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
title_fullStr Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
title_full_unstemmed Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
title_short Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
title_sort corrigendum identification of microtube associated biomarkers in diffuse large b cell lymphoma and prognosis prediction
topic DLBCL
microtube-associated genes
prognostic model
targeting therapy
TMEM63A
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1180076/full
work_keys_str_mv AT wenqiwu corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT suliu corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT linyantian corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT chengli corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT yananjiang corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT jinhuanwang corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT yangyanglv corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT jingguo corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT donghuixing corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT yixinzhai corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT huimengsun corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT yuhangli corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT luyingzhang corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT xianghe corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT kaipingluo corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT hongjiezhan corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT zhigangzhao corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction
AT zhigangzhao corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction